Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

Description

This study assesses two active treatments in different sequences and a standard of care group among infants with cerebral palsy.

Conditions

Cerebral Palsy

Talk to us

Study Overview

On this page

Study Details

Study overview

This study assesses two active treatments in different sequences and a standard of care group among infants with cerebral palsy.

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

Condition
Cerebral Palsy
Intervention / Treatment

-

Contacts and Locations

Atlanta

Emory University, Atlanta, Georgia, United States, 30322

Baltimore

Kennedy Krieger Institute, Baltimore, Maryland, United States, 21205

Philadelphia

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States, 19104

Salt Lake City

The University of Utah, Salt Lake City, Utah, United States, 84112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Aged 4 to 13 months, corrected age
  • * Patient at a participating neonatal intensive care unit (NICU) Early Developmental Clinic, outpatient physical and occupational therapy clinic and stroke clinic
  • * Diagnosis of CP or classification of high-risk for CP as determined by published guidelines (\>95% risk of later CP)
  • * Hammersmith Infant Neurological Exam (HINE) arm asymmetry score of greater than or equal to 2 and/or neuroimaging consistent with perinatal involvement
  • * Hand Assessment for Infants (HAI) difference between hands ≥2, with an observable and relative difference in quality or amount of movement between hands, as determined by HAI-certified study therapists and/or a unimanual Bayley score difference between hands \>1
  • * Parent/legal guardian is able to provide informed consent
  • * Congenital malformation of the brain or musculoskeletal system (MSK)
  • * Receipt of botulinum toxin to the affected extremity within 3 months of study entry
  • * Any prior long-term hard constraint programs

Ages Eligible for Study

4 Months to 13 Months

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Emory University,

Nathalie Maitre, MD, PhD, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

2027-02-28